How should I evaluate and manage a patient with persistent diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Persistent Diarrhea

Begin with a detailed history focusing on duration, stool characteristics, travel history, medication use, and surgical history, followed by screening blood tests (complete blood count, celiac serology) and stool tests (calprotectin, culture, ova and parasites) to guide your diagnostic pathway. 1

Initial Clinical Assessment

History and Physical Examination

Obtain specific details about:

  • Duration: Persistent diarrhea is defined as ≥14 days 2
  • Stool characteristics: Frequency, consistency, presence of blood or mucus 1
  • Travel history: Approximately 3% of travelers to developing countries develop persistent diarrhea 2, 3
  • Medication review: Many drugs cause chronic diarrhea 4
  • Surgical history: Prior bowel resection, cholecystectomy, or radiation therapy 4
  • Red flag symptoms: Blood in stool, weight loss, anemia, palpable abdominal mass 5

First-Line Laboratory Testing

Order the following screening tests immediately 1:

  • Blood tests: Complete blood count (to exclude anemia), celiac serology (tissue transglutaminase antibodies), thyroid function 1
  • Stool tests: Fecal calprotectin (to exclude inflammation), stool culture, ova and parasites examination 1
  • Fecal immunochemical test (FIT): Consider in patients without rectal bleeding to guide investigation priority 1

Risk Stratification and Urgent Referral

Patients Requiring Immediate Gastroenterology Referral

Refer urgently if any of the following are present 5:

  • Blood in stool
  • Unintentional weight loss
  • Clinical or laboratory signs of anemia
  • Palpable abdominal mass
  • Age >40 with new-onset symptoms and positive fecal calprotectin 1

Patients Requiring Colonoscopy

Exclude colorectal cancer via colonoscopy in all patients with altered bowel habit ± rectal bleeding 1. This is a strong recommendation based on level 1 evidence.

Diagnostic Pathway Based on Initial Results

If Initial Tests Are Normal: Consider IBS vs. Functional Diarrhea

After basic screening excludes organic disease, you can make a positive diagnosis of irritable bowel syndrome (IBS) 1. However, proceed to test for commonly missed diagnoses:

Test for Bile Acid Diarrhea

Perform SeHCAT testing or measure serum 7α-hydroxy-4-cholesten-3-one (C4) to diagnose bile acid diarrhea rather than empirical treatment 1. This is particularly important in patients with functional bowel symptoms or IBS-diarrhea phenotype.

Exclude Microscopic Colitis

Perform colonoscopy with biopsies from the right and left colon (not rectum) to exclude microscopic colitis 1. This is essential as microscopic colitis cannot be diagnosed without histology.

If Inflammatory Markers Are Elevated

  • Fecal calprotectin >50 μg/g: Proceed to colonoscopy to evaluate for inflammatory bowel disease 1
  • Obtain biopsies even if mucosa appears normal endoscopically 1

If Infectious Etiology Is Suspected

Common Pathogens in Persistent Diarrhea

The most common causes include 2, 6:

  • Parasites: Giardia, Cryptosporidium (most common)
  • Bacteria: Enteroaggregative E. coli, Shigella
  • In endemic areas: Schistosoma mansoni

Diagnostic Testing for Infections

  • Stool microscopy: Three separate stool samples for ova and parasites 3
  • Multiplex PCR panels: More sensitive than culture for bacterial, viral, and protozoal pathogens 2
  • Special populations: Immunocompromised and elderly patients require more extensive infectious workup 1

Empirical Antimicrobial Therapy

For travelers returning from developing countries, empirical antibiotics targeting bacterial enteropathogens can be given without waiting for test results 3. If symptoms persist after bacterial treatment, empirical antiprotozoal therapy (e.g., metronidazole for Giardia) may be employed 3.

Secondary Assessment for Persistent Symptoms

When to Pursue Further Investigation

If symptoms persist despite normal first-line investigations and treatment, proceed with 1:

Malabsorption Workup

  • Fecal elastase: Test when fat malabsorption is suspected (do not use PABA testing) 1
  • Lactose breath testing: If lactose maldigestion suspected, or trial dietary lactose withdrawal 1
  • Celiac disease: Should already be excluded in initial screening 1

Small Bowel Imaging

Choose between 1:

  • MR enterography: Preferred modality for small bowel evaluation
  • Video capsule endoscopy: Alternative depending on local availability
  • Do not use barium studies: Small bowel follow-through has poor sensitivity and specificity 1

Enteroscopy

Reserve enteroscopy only for targeted biopsy or treatment of lesions already identified by MR enterography or capsule endoscopy—not as a primary diagnostic tool 1.

Management Approach

Specific Treatment When Etiology Identified

  • Giardia: Metronidazole or tinidazole 6
  • Bile acid diarrhea: Bile acid sequestrants (cholestyramine, colesevelam) 1
  • Microscopic colitis: Budesonide 1
  • Bacterial overgrowth: Rifaximin 4
  • Pancreatic insufficiency: Pancreatic enzyme replacement 1

Symptomatic Treatment

For patients without identified etiology or while awaiting test results 4:

  • Loperamide for symptom control
  • Dietary modifications based on suspected triggers
  • Reassurance that prognosis is generally good even when no cause is found 3

Common Pitfalls to Avoid

  • Do not diagnose IBS without excluding celiac disease and inflammation via blood tests and fecal calprotectin 1
  • Do not skip bile acid diarrhea testing in patients with functional symptoms—this is a frequently missed diagnosis 1
  • Do not biopsy only the rectum when evaluating for microscopic colitis; right and left colon biopsies are required 1
  • Do not use empirical bile acid sequestrant trials instead of making a positive diagnosis with testing 1
  • Do not order enteroscopy as a first-line test—it should only follow abnormal MR enterography or capsule endoscopy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Persistent diarrhea in travelers.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996

Research

Chronic Diarrhea: Diagnosis and Management.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017

Research

Diarrhea as a Clinical Challenge: General Practitioner Approach.

Digestive diseases (Basel, Switzerland), 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.